Monday, October 26, 2020 2:16:19 AM
You could just read the descriptions at the USPO that the applications had ?
SAMIAIR
NeuroRx, Inc.
USPTO Trademarks › NeuroRx, Inc. › Samiair Application #90179858
Application Filed: 2020-09-14
Trademark Application Details
Trademark Logo SAMIAIR
Mark For: SAMIAIR™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectio nous diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of Sarcoidosis; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations, namely, antivirals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with Vasoactive Intestinal Peptide
Samivir
Neurorx, Inc.
USPTO Trademarks › Neurorx, Inc. › Samivir Application #90087709
Trademark Logo SAMIVIR
Mark For: SAMIVIR™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
SAMIAIR
NeuroRx, Inc.
USPTO Trademarks › NeuroRx, Inc. › Samiair Application #90179858
Application Filed: 2020-09-14
Trademark Application Details
Trademark Logo SAMIAIR
Mark For: SAMIAIR™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectio nous diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of Sarcoidosis; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations, namely, antivirals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with Vasoactive Intestinal Peptide
Samivir
Neurorx, Inc.
USPTO Trademarks › Neurorx, Inc. › Samivir Application #90087709
Trademark Logo SAMIVIR
Mark For: SAMIVIR™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
